Loading…
Based on limited metadata, this warning letter was issued to Novoliq, Inc., a tobacco product company, on March 6, 2019. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA tobacco product regulation, though the specific issuing office is not identified in the metadata provided. Additional documentation would be needed to determine the precise regulatory concerns that prompted this warning.